针对癌症治疗中药物反应预测的优化模型和深度学习方法:一篇综述
Wesam Ibrahim Hajim1,2, Suhaila Zainudin2, Kauthar Mohd Daud2
1Department of Applied Geology, College of Sciences, Tirkit University, Tikrit, Salah ad Din, Iraq.
PeerJ. Computer science
|April 25, 2024
概括
深度学习 (DL) 模型显著提升了针对个性化癌症护理的药物反应预测 (DRP). 未来的研究应该提高模型的通用性,互操作性和可解释性,以提高临床信任和精确瘤学.
科学领域:
- 计算生物学是一种计算生物学.
- 医疗信息学医学信息学
- 医学中的人工智能
背景情况:
- 深度学习 (DL) 对于推进个性化医疗保健至关重要,特别是预测癌症患者的药物反应.
- DL技术已成为医疗领域不可或缺的工具,推动治疗策略的创新.
研究的目的:
- 审查和分析不同DL模型在癌症患者药物反应预测 (DRP) 中的有效性.
- 通过从2017-2023年进行的研究,确定DL应用中的关键重点领域和趋势.
主要方法:
- 2017年至2023年间发表的DL模型应用于癌症中DRP的系统审查.
- 利用VOS-Viewer软件从研究标题和摘要生成一个词云,以可视化研究主题.
主要成果:
- 词云分析突出了关键术语和分组主题,包括深度学习,机器学习,精准医学,精准瘤学,药物反应预测和个性化医学.
- 确定了这些关键词之间的强烈相互联系,表明当前的研究重点领域.
结论:
- 提高DL模型的通用性和互操作性对于推进DRP至关重要.
- 未来的工作应该集中在简化DL架构和提高模型可解释性,以促进临床信任和促进精确瘤学.
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
69
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
69
Pharmacokinetic Models: Overview
667
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
667
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Pharmacokinetic Models: Comparison and Selection Criterion
69
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
69


